Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02704208 · ClinicalTrials.gov registry record · NA

A Technology-Delivered Peer-to-Peer Support ART Adherence Intervention for Substance-using HIV+ Adults

A NA study of HIV, sponsored by University of Minnesota.

Completed
Registry status
NA
Development phase
410
Enrollment target
1
Study location

NCT02704208: Completed NA study of HIV, sponsored by University of Minnesota.

NCT02704208 is a NA study of HIV that has completed, run by University of Minnesota. The registered enrollment target is 410 participants, roughly in line with the 439-participant average among 303 other HIV trials with a reported enrollment target. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02704208, a NA study of HIV, has completed, sponsored by University of Minnesota.

COMPLETED
Registry status
NA
Development phase
410 participants
Enrollment target
1
Study location

Study Summary

The "Thrive With Me" (TWM) trial is testing the efficacy of a mobile enhanced website aimed at improving Antiretroviral Therapy (ART) adherence for HIV-positive men who have sex with men (MSM). TWM is a technology-delivered peer-to-peer social support intervention with social networking and gaming components. In addition to real-time peer-to-peer support capabilities, the TWM intervention provides participants with Antiretroviral Therapy (ART) adherence self-monitoring tools, medication dose reminders, and HIV-related informational content.

Primary Outcome

Undetectable viral load (plasma viral load is considered undetectable at \<20 copies/mm3)

Conditions Studied

Interventions

  • BEHAVIORAL Thrive With Me Control
  • BEHAVIORAL Thrive With Me Intervention

Study Locations (1)

New York

  • Center for HIV Education Studies and Training, Hunter College - New York

Trial Details

FieldValue
Enrollment Target 410 participants
Start Date 2016-10-01
Est. Completion 2022-05-31
Phase NA
University of Minnesota

966 total trials

What the finished NCT02704208 record still lists

NCT02704208 is an interventional study that assigns participants to a tested intervention. The registered 410 participants enrollment target is mid-sized for trials with a published cap, roughly in line with the 439-participant average among 303 other HIV trials with a reported enrollment target.

The record links to 1 condition, with HIV appearing as the primary indexed condition, and to 2 interventions - of which Thrive With Me Control is the first listed.

NCT02704208 reports a single indexed study location in New York.

Frequently Asked Questions

What is clinical trial NCT02704208 about?

NCT02704208 is a clinical study titled "A Technology-Delivered Peer-to-Peer Support ART Adherence Intervention for Substance-using HIV+ Adults". The "Thrive With Me" (TWM) trial is testing the efficacy of a mobile enhanced website aimed at improving Antiretroviral Therapy (ART) adherence for HIV-positive men who have sex with men (MSM). TWM is a technology-delivered peer-to-peer social support intervention with social networking and gaming c...

What is the current status of trial NCT02704208?

This trial is currently completed. It is a NA study. The enrollment target is 410 participants. The study started on 2016-10-01. Estimated completion is 2022-05-31.

What conditions does trial NCT02704208 study?

This clinical trial studies the following conditions: HIV.

What interventions are being tested in trial NCT02704208?

The interventions under investigation include: Thrive With Me Control (BEHAVIORAL), Thrive With Me Intervention (BEHAVIORAL).

Who is sponsoring clinical trial NCT02704208?

This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02704208 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for HIV

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT02704208's enrollment target sits among peer trials

410 38th of 303 higher than 266 of 303 other HIV trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other HIV trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02043691 · 410 participants · NA

    Evaluation of the Cook Custom Aortic Endograft, the Zenith t-Branch Endovascular Graft, and Surgeon-Modified Endograft in Treating Aortic Pathologies

  • NCT03042975 · 410 participants

    Imaging Genetics of Laryngeal Dystonia

  • NCT05730036 · 410 participants · Phase 3

    A Trial to Learn How Well Linvoseltamab Works Compared to the Combination of Elotuzumab, Pomalidomide and Dexamethasone for Adult Participants With Relapsed/Refractory Multiple Myeloma

  • NCT05751473 · 410 participants · NA

    Reducing Posttraumatic Stress Disorder (PTSD) Symptoms in First Responders and Frontline Health Care Workers

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT02704208, the US trial registry maintained by the National Library of Medicine. NCT02704208 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.